Publications by authors named "Xiangyun Dou"

Claim this Profile
S
Safety issues of tofacitinib in rheumatoid arthritis patients: real-world pharmacovigilance.
Yi Zeng, Jiazhen Jiang, Dongqiang Luo, Bohui Zheng, Manting Liu, Xiangyun Dou

Expert Opin Drug Saf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse tumor events induced by ranitidine: an analysis based on the FAERS database.
ManTing Liu, DongQiang Luo, JiaZhen Jiang, Ying Shao, DanDan Dai, XiangYun Dou

Expert Opin Drug Saf· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System.
Shulan Huang, Hanlin Dong, Dongqiang Luo, Jiazhen Jiang, Manting Liu, Xiangyun Dou

Expert Opin Drug Saf· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of TNF-α inhibitors: A real-world study based on the US FDA Adverse Event Reporting System Database.
Bohui Zheng, Manting Liu, Dandan Dai, Yifan Shang, Xiangyun Dou

Medicine (Baltimore)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin K2 ameliorates osteoarthritis by suppressing ferroptosis and extracellular matrix degradation through activation GPX4's dual functions.
Qi He, Yuewei Lin, Baihao Chen, Chuyi Chen, Jiaxu Zeng, Xiangyun Dou

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway.
Shaocong Li, Qi He, Baihao Chen, Jiaxu Zeng, Xiangyun Dou

Sci Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis